Rheumatology Therapeutics Market Size, Share, Trends, Growth and Forecast 2032
Rheumatology Therapeutics Market By Disease Type (Rheumatoid Arthritis, Ankylosing spondylitis, Osteoarthritis, Lupus, Gout, and Other), Drug Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Disease Modifying Anti-Rheumatic Drugs (DMARDs), Corticosteroids, and Others) By Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals, and Other): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 35.47 Billion | USD 44.29 Billion | 2.5% | 2023 |
Table Of Content
- Chapter No. 1 Introduction
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. USP & Key Offerings
- 1.2. Key Benefits for Drug Types
- 1.3. Target Audience
- 1.4. Report Scope
- 1.1. Report Description
- Chapter No. 2 Executive Summary
- 2.1. Key Findings
- 2.1.1. Top Investment Pockets
- 2.1.1.1. Market Attractiveness Analysis, By Disease Type
- 2.1.1.2. Market Attractiveness Analysis, By Drug Type
- 2.1.1.4. Market Attractiveness Analysis, By Distribution Channel
- 2.1.1.5. Market Attractiveness Analysis, By Region
- 2.1.1. Top Investment Pockets
- 2.2. Market Snapshot
- 2.3. Global Rheumatulogy Therapeutics Market, 2016 – 2028 (USD Billion)
- 2.4. Insights from Primary Respondents
- 2.1. Key Findings
- Chapter No. 3 COVID 19 Impact Analysis
- 3.1. Impact Assessment of COVID-19 Pandemic, By Region
- 3.1.1. North America
- 3.1.2. Europe
- 3.1.3. Asia Pacific
- 3.1.4. Latin America
- 3.1.5. The Middle-East and Africa
- 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
- 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
- 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
- 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
- 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
- 3.6. Short Term Dynamics
- 3.7. Long Term Dynamics
- 3.1. Impact Assessment of COVID-19 Pandemic, By Region
- Chapter No. 4 Rheumatulogy Therapeutics Market – Disease Type Segment Analysis
- 4.1. Overview
- 4.1.1. Market Revenue Share, By Disease Type, 2020 & 2028
- 4.2. Rheumatoid Arthritis
- 4.2.1. Market Size and Forecast, By Region (USD Billion)
- 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 4.2.3. Key Market Trends, Growth Factors, & Opportunities
- 4.3. Ankylosing spondylitis
- 4.3.1. Market Size and Forecast, By Region (USD Billion)
- 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 4.3.3. Key Market Trends, Growth Factors, & Opportunities
- 4.5. Osteoarthritis
- 4.5.1. Market Size and Forecast, By Region (USD Billion)
- 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 4.5.3. Key Market Trends, Growth Factors, & Opportunities
- 4.6. Lupus
- 4.6.1. Market Size and Forecast, By Region (USD Billion)
- 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 4.6.3. Key Market Trends, Growth Factors, & Opportunities
- 4.7. Gout
- 4.7.1. Market Size and Forecast, By Region (USD Billion)
- 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 4.7.3. Key Market Trends, Growth Factors, & Opportunities
- 4.8. Other
- 4.8.1. Market Size and Forecast, By Region (USD Billion)
- 4.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 4.8.3. Key Market Trends, Growth Factors, & Opportunities
- 4.1. Overview
- Chapter No. 5 Rheumatulogy Therapeutics Market – Drug Type Segment Analysis
- 5.1. Overview
- 5.1.1. Market Revenue Share, By Drug Type, 2020 & 2028
- 5.2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- 5.2.1. Market Size and Forecast, By Region (USD Billion)
- 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 5.2.3. Key Market Trends, Growth Factors, & Opportunities
- 5.3. Analgesics
- 5.3.1. Market Size and Forecast, By Region (USD Billion)
- 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 5.3.3. Key Market Trends, Growth Factors, & Opportunities
- 5.4. Disease Modifying Anti-Rheumatic Drugs (DMARDs)
- 5.4.1. Market Size and Forecast, By Region (USD Billion)
- 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 5.4.3. Key Market Trends, Growth Factors, & Opportunities
- 5.5. Corticosteroids
- 5.5.1. Market Size and Forecast, By Region (USD Billion)
- 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 5.5.3. Key Market Trends, Growth Factors, & Opportunities
- 5.6. Others
- 5.6.1. Market Size and Forecast, By Region (USD Billion)
- 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 5.6.3. Key Market Trends, Growth Factors, & Opportunities
- 5.1. Overview
- Chapter No. 7 Rheumatulogy Therapeutics Market – Distribution Channel Segment Analysis
- 7.1. Overview
- 7.1.1. Market Revenue Share, By Service, 2020 & 2028
- 7.2. Retail Pharmacy
- 7.2.1. Market Size and Forecast, By Region (USD Billion)
- 7.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 7.2.3. Key Market Trends, Growth Factors, & Opportunities
- 7.3. Online Pharmacy
- 7.3.1. Market Size and Forecast, By Region (USD Billion)
- 7.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 7.3.3. Key Market Trends, Growth Factors, & Opportunities
- 7.4. Hospitals
- 7.4.1. Market Size and Forecast, By Region (USD Billion)
- 7.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 7.4.3. Key Market Trends, Growth Factors, & Opportunities
- 7.5. Other
- 7.5.1. Market Size and Forecast, By Region (USD Billion)
- 7.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
- 7.5.3. Key Market Trends, Growth Factors, & Opportunities
- 7.1. Overview
- Chapter No. 8 Rheumatulogy Therapeutics Market – Regional Analysis
- 8.1. Overview
- 8.1.1. Global Market Revenue Share, By Region, 2020 & 2028
- 8.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
- 8.2. North America
- 8.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
- 8.2.2. North America Market Revenue, By Disease Type, 2016 – 2028
- 8.2.3. North America Market Revenue, By Drug Type, 2016 – 2028
- 8.2.4. North America Market Revenue, By Distribution Channel, 2016 – 2028
- 8.2.6. U.S.
- 8.2.6.1. U.S. Market Revenue, By Disease Type, 2016 – 2028
- 8.2.6.2. U.S. Market Revenue, By Drug Type, 2016 – 2028
- 8.2.6.3. U.S. Market Revenue, By Distribution Channel, 2016 – 2028
- 8.2.7. Canada
- 8.2.7.1. Canada Market Revenue, By Disease Type, 2016 – 2028
- 8.2.7.2. Canada Market Revenue, By Drug Type, 2016 – 2028
- 8.2.7.3. Canada Market Revenue, By Distribution Channel, 2016 – 2028
- 8.2.8. Mexico
- 8.2.8.1. Mexico Market Revenue, By Disease Type, 2016 – 2028
- 8.2.8.2. Mexico Market Revenue, By Drug Type, 2016 – 2028
- 8.2.8.3. Mexico Market Revenue, By Distribution Channel, 2016 – 2028
- 8.3. Europe
- 8.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
- 8.3.2. Europe Market Revenue, By Disease Type, 2016 – 2028
- 8.3.3. Europe Market Revenue, By Drug Type, 2016 – 2028
- 8.3.4. Europe Market Revenue, By Distribution Channel, 2016 – 2028
- 8.3.6. Germany
- 8.3.6.1. Germany Market Revenue, By Disease Type, 2016 – 2028
- 8.3.6.2. Germany Market Revenue, By Drug Type, 2016 – 2028
- 8.3.6.3. Germany Market Revenue, By Distribution Channel, 2016 – 2028
- 8.3.7. France
- 8.3.7.1. France Market Revenue, By Disease Type, 2016 – 2028
- 8.3.7.2. France Market Revenue, By Drug Type, 2016 – 2028
- 8.3.7.3. France Market Revenue, By Distribution Channel, 2016 – 2028
- 8.3.8. U.K.
- 8.3.8.1. U.K. Market Revenue, By Disease Type, 2016 – 2028
- 8.3.8.2. U.K. Market Revenue, By Drug Type, 2016 – 2028
- 8.3.8.3. U.K. Market Revenue, By Distribution Channel, 2016 – 2028
- 8.3.9. Italy
- 8.3.9.1. Italy Market Revenue, By Disease Type, 2016 – 2028
- 8.3.9.2. Italy Market Revenue, By Drug Type, 2016 – 2028
- 8.3.9.3. Italy Market Revenue, By Distribution Channel, 2016 – 2028
- 8.3.10. Spain
- 8.3.10.1. Spain Market Revenue, By Disease Type, 2016 – 2028
- 8.3.10.2. Spain Market Revenue, By Drug Type, 2016 – 2028
- 8.3.10.3. Spain Market Revenue, By Distribution Channel, 2016 – 2028
- 8.3.11. Rest of Europe
- 8.3.11.1. Rest of Europe Market Revenue, By Disease Type, 2016 – 2028
- 8.3.11.2. Rest of Europe Market Revenue, By Drug Type, 2016 – 2028
- 8.3.11.3. Rest of Europe Market Revenue, By Distribution Channel, 2016 – 2028
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
- 8.4.2. Asia Pacific Market Revenue, By Disease Type, 2016 – 2028
- 8.4.3. Asia Pacific Market Revenue, By Drug Type, 2016 – 2028
- 8.4.4. Asia Pacific Market Revenue, By Distribution Channel, 2016 – 2028
- 8.4.6. China
- 8.4.6.1. China Market Revenue, By Disease Type, 2016 – 2028
- 8.4.6.2. China Market Revenue, By Drug Type, 2016 – 2028
- 8.4.5.3. China Market Revenue, By Distribution Channel, 2016 – 2028
- 8.4.6. Japan
- 8.4.6.1. Japan Market Revenue, By Disease Type, 2016 – 2028
- 8.4.6.2. Japan Market Revenue, By Drug Type, 2016 – 2028
- 8.4.6.3. Japan Market Revenue, By Distribution Channel, 2016 – 2028
- 8.4.7. India
- 8.4.7.1. India Market Revenue, By Disease Type, 2016 – 2028
- 8.4.7.2. India Market Revenue, By Drug Type, 2016 – 2028
- 8.4.7.3. India Market Revenue, By Distribution Channel, 2016 – 2028
- 8.4.8. South Korea
- 8.4.8.1. South Korea Market Revenue, By Disease Type, 2016 – 2028
- 8.4.8.2. South Korea Market Revenue, By Drug Type, 2016 – 2028
- 8.4.8.3. South Korea Market Revenue, By Distribution Channel, 2016 – 2028
- 8.4.9. South-East Asia
- 8.4.9.1. South-East Asia Market Revenue, By Disease Type, 2016 – 2028
- 8.4.9.2. South-East Asia Market Revenue, By Drug Type, 2016 – 2028
- 8.4.9.3. South-East Asia Market Revenue, By Distribution Channel, 2016 – 2028
- 8.4.10. Rest of Asia Pacific
- 8.4.10.1. Rest of Asia Pacific Market Revenue, By Disease Type, 2016 – 2028
- 8.4.10.2. Rest of Asia Pacific Market Revenue, By Drug Type, 2016 – 2028
- 8.4.10.3. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2016 – 2028
- 8.5. Latin America
- 8.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
- 8.5.2. Latin America Market Revenue, By Disease Type, 2016 – 2028
- 8.5.3. Latin America Market Revenue, By Drug Type, 2016 – 2028
- 8.5.4. Latin America Market Revenue, By Distribution Channel, 2016 – 2028
- 8.5.6. Brazil
- 8.5.6.1. Brazil Market Revenue, By Disease Type, 2016 – 2028
- 8.5.6.2. Brazil Market Revenue, By Drug Type, 2016 – 2028
- 8.5.6.3. Brazil Market Revenue, By Distribution Channel, 2016 – 2028
- 8.5.7. Argentina
- 8.5.7.1. Argentina Market Revenue, By Disease Type, 2016 – 2028
- 8.5.7.2. Argentina Market Revenue, By Drug Type, 2016 – 2028
- 8.5.7.3. Argentina Market Revenue, By Distribution Channel, 2016 – 2028
- 8.5.8. Rest of Latin America
- 8.5.8.1. Rest of Latin America Market Revenue, By Disease Type, 2016 – 2028
- 8.5.8.2. Rest of Latin America Market Revenue, By Drug Type, 2016 – 2028
- 8.5.8.3. Rest of Latin America Market Revenue, By Distribution Channel, 2016 – 2028
- 8.6. The Middle-East and Africa
- 8.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
- 8.6.2. The Middle-East and Africa Market Revenue, By Disease Type, 2016 – 2028
- 8.6.3. The Middle-East and Africa Market Revenue, By Drug Type, 2016 – 2028
- 8.6.3. The Middle-East and Africa Market Revenue, By Distribution Channel, 2016 – 2028
- 8.6.5. GCC Countries
- 8.6.5.1. GCC Countries Market Revenue, By Disease Type, 2016 – 2028
- 8.6.5.2. GCC Countries Market Revenue, By Drug Type, 2016 – 2028
- 8.6.5.3. GCC Countries Market Revenue, By Distribution Channel, 2016 – 2028
- 8.6.6. South Africa
- 8.6.6.1. South Africa Market Revenue, By Disease Type, 2016 – 2028
- 8.6.6.2. South Africa Market Revenue, By Drug Type, 2016 – 2028
- 8.6.6.3. South Africa Market Revenue, By Distribution Channel, 2016 – 2028
- 8.6.7. Rest of Middle-East Africa
- 8.6.7.1. Rest of Middle-East Africa Market Revenue, By Disease Type, 2016 – 2028
- 8.6.7.2. Rest of Middle-East Africa Market Revenue, By Drug Type, 2016 – 2028
- 8.6.7.3. Rest of Middle-East Africa Market Revenue, By Distribution Channel, 2016 – 2028
- 8.1. Overview
- Chapter No. 8 Rheumatulogy Therapeutics Market – Industry Analysis
- 8.1. Introduction
- 8.2. Market Drivers
- 8.2.1. Driving Factor 1 Analysis
- 8.2.2. Driving Factor 2 Analysis
- 8.3. Market Restraints
- 8.3.1. Restraining Factor Analysis
- 8.4. Market Opportunities
- 8.4.1. Market Opportunity Analysis
- 8.5. Porter’s Five Forces Analysis
- 8.6. PEST Analysis
- 8.7. Regulatory Landscape
- 8.8. Service Landscape
- 8.9. Regional Market Trends
- 8.9.1. North America
- 8.9.2. Europe
- 8.9.3. Asia Pacific
- 8.9.4. Latin America
- 8.9.5. The Middle-East and Africa
- 8.10. Pricing Analysis
- 8.11. Value Chain Analysis
- 8.12. Downstream Buyers
- 8.13. Distributors/Traders List
- Chapter No. 9 Competitive Landscape
- 9.1. Company Market Share Analysis – 2019
- 9.1.1. Global Rheumatulogy Therapeutics Market: Company Market Share, 2019
- 9.1.2. Global Rheumatulogy Therapeutics Market, Company Market Revenue, 2016 – 2019 (USD Billion)
- 9.1.3. Global Rheumatulogy Therapeutics Market, Company Y-o-Y Growth, 2017 – 2019 (%)
- 9.1.4. Global Rheumatulogy Therapeutics Market: Radar Determinant Chart, 2019
- 9.2. Strategic Developments
- 9.2.1. Acquisitions & Mergers
- 9.2.2. New Product Launch
- 9.2.3. Regional Expansion
- 9.3. Company Strategic Developments – Heat Map Analysis
- 9.1. Company Market Share Analysis – 2019
- Chapter No. 10 Company Profiles
- 10.1. ABBVIE, INC.
- 10.1.1. Company Overview
- 10.1.2. Key Executives
- 10.1.3. Product Portfolio
- 10.1.4. Financial Overview
- 10.1.5. Operating Business Segments
- 10.1.6. Business Performance
- 10.1.7. Recent Developments
- 10.2. Diabetizer Ltd. & Co. KG
- 10.3. Pfizer, Inc.
- 10.4. Bristul-Myers Squibb Company
- 10.5. Merck & Co., Inc.
- 10.6. Amgen, Inc.
- 10.7. Janssen Biotech, Inc.
- 10.8. Novartis AG
- 10.9. Genentech, Inc.
- 10.10. Takeda Pharmaceutical
- 10.1. ABBVIE, INC.
- Chapter No. 11 Marketing Strategy Analysis
- 11.1. Marketing Channel
- 11.2. Direct Marketing
- 11.3. Indirect Marketing
- 11.4. Marketing Channel Development Trends
- 11.5. Economic/Pulitical Environmental Change
- Chapter No. 12 Research Methodology
- 12.1. Research Methodology
- 12.2. Phase I - Secondary Research
- 12.3. Phase II - Data Modeling
- 12.3.1. Company Share Analysis Model
- 12.3.2. Revenue Based Modeling
- 12.4. Phase III - Primary Research
- 12.5. Research Limitations
- 12.5.1. Assumptions
Table Of Figures
List of Figures
FIG NO. 1. Market Attractiveness Analysis, By Disease Type
FIG NO. 2. Market Attractiveness Analysis, By Drug Type
FIG NO. 4. Market Attractiveness Analysis, By Distribution Channel
FIG NO. 5. Market Attractiveness Analysis, By Region
FIG NO. 6. Global Rheumatology Therapeutics Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 7. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 8. Market Revenue Share, By Disease Type, 2020 & 2028
FIG NO. 9. Global Rheumatology Therapeutics Market for Rheumatoid Arthritis, Revenue (USD Billion) 2016 – 2028
FIG NO.10. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Rheumatoid Arthritis, By Country, 2020 & 2028
FIG NO. 11. Global Rheumatology Therapeutics Market for Ankylosing spondylitis, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Ankylosing spondylitis, By Country, 2020 & 2028
FIG NO. 13. Global Rheumatology Therapeutics Market for Osteoarthritis, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Lupus, By Country, 2020 & 2028
FIG NO. 15. Global Rheumatology Therapeutics Market for Lupus, Revenue (USD Billion) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Gout, By Country, 2020 & 2028
FIG NO. 17. Global Rheumatology Therapeutics Market for Gout, Revenue (USD Billion) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Other, By Country, 2020 & 2028
FIG NO. 19. Global Rheumatology Therapeutics Market for Other, Revenue (USD Billion) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Osteoarthritis, By Country, 2020 & 2028
FIG NO. 21. Market Revenue Share, By Drug Type, 2020 & 2028
FIG NO. 22. Global Rheumatology Therapeutics Market for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Revenue (USD Billion) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), By Country, 2020 & 2028
FIG NO. 24. Global Rheumatology Therapeutics Market for Analgesics, Revenue (USD Billion) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Analgesics, By Country, 2020 & 2028
FIG NO. 26. Global Rheumatology Therapeutics Market for Disease Modifying Anti-Rheumatic Drugs (DMARDs), Revenue (USD Billion) 2016 – 2028
FIG NO. 27. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Disease Modifying Anti-Rheumatic Drugs (DMARDs), By Country, 2020 & 2028
FIG NO. 28. Global Rheumatology Therapeutics Market for Corticosteroids, Revenue (USD Billion) 2016 – 2028
FIG NO. 29. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Corticosteroids, By Country, 2020 & 2028
FIG NO. 30. Global Rheumatology Therapeutics Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Others, By Country, 2020 & 2028
FIG NO. 32. Market Revenue Share, By Distribution Channel, 2020 & 2028
FIG NO. 33. Global Rheumatology Therapeutics Market for Retail Pharmacy, Revenue (USD Billion) 2016 – 2028
FIG NO. 34. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Retail Pharmacy, By Country, 2020 & 2028
FIG NO. 35. Global Rheumatology Therapeutics Market for Online Pharmacy, Revenue (USD Billion) 2016 – 2028
FIG NO. 36. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Online Pharmacy, By Country, 2020 & 2028
FIG NO. 37. Global Rheumatology Therapeutics Market for Hospitals, Revenue (USD Billion) 2016 – 2028
FIG NO. 38. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Hospitals, By Country, 2020 & 2028
FIG NO. 39. Global Rheumatology Therapeutics Market for Other, Revenue (USD Billion) 2016 – 2028
FIG NO. 40. Comparative Revenue Analysis of Rheumatology Therapeutics Market for Other, By Country, 2020 & 2028
FIG NO. 41. Global Rheumatology Therapeutics Market Revenue Share, By Region, 2020 & 2028
FIG NO. 42. North America Rheumatology Therapeutics Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 43. Porter’s Five Forces Analysis for Global Rheumatology Therapeutics Market
FIG NO. 44. PEST Analysis for Global Rheumatology Therapeutics Market
FIG NO. 45. Pricing Analysis for Global Rheumatology Therapeutics Market
FIG NO. 46. Value Chain Analysis for Global Rheumatology Therapeutics Market
FIG NO. 47. Company Share Analysis, 2019
FIG NO. 48. Radar Determinant Chart, 2019
FIG NO. 49. Company Strategic Developments – Heat Map Analysis
FIG NO. 50. ABBVIE, INC. Business Segment Revenue Share, 2020 (%)
FIG NO. 51. ABBVIE, INC. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 52. Market Channels
FIG NO. 53. Marketing Channel Development Trend
FIG NO. 54. Growth in World Gross Product, 2008-2018
FIG NO. 55. Research Methodology – Detailed View
FIG NO. 56. Research Methodology
Table Of Tables
List of Tables
TABLE NO. 1. Global Rheumatology Therapeutics Market: Snapshot
TABLE NO. 2. Quarterly Rheumatology Therapeutics Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Rheumatology Therapeutics Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
TABLE NO. 6. Global Rheumatology Therapeutics Market for Rheumatoid Arthritis, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Rheumatology Therapeutics Market for Ankylosing spondylitis, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Rheumatology Therapeutics Market for Osteoarthritis, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Rheumatology Therapeutics Market for Lupus, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Rheumatology Therapeutics Market for Gout, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. Global Rheumatology Therapeutics Market for Other, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Rheumatology Therapeutics Market for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Rheumatology Therapeutics Market for Analgesics, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14. Global Rheumatology Therapeutics Market for Disease Modifying Anti-Rheumatic Drugs (DMARDs), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Rheumatology Therapeutics Market for Corticosteroids, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. Global Rheumatology Therapeutics Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 17. Global Rheumatology Therapeutics Market for Retail Pharmacy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 18. Global Rheumatology Therapeutics Market for Online Pharmacy, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 19. Global Rheumatology Therapeutics Market for Hospitals, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 20. Global Rheumatology Therapeutics Market for Other, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 21. Global Rheumatology Therapeutics Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 22. North America Rheumatology Therapeutics Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 23. North America Rheumatology Therapeutics Market Revenue, By Disease Type, 2016 – 2028 (USD Billion)
TABLE NO. 24. North America Rheumatology Therapeutics Market Revenue, By Drug Type, 2016 – 2028 (USD Billion)
TABLE NO. 25. North America Rheumatology Therapeutics Market Revenue, By Distribution Channel, 2016 – 2028 (USD Billion)
TABLE NO. 26. U.S. Rheumatology Therapeutics Market Revenue, By Disease Type, 2016 – 2028 (USD Billion)
TABLE NO. 27. U.S. Rheumatology Therapeutics Market Revenue, By Drug Type, 2016 – 2028 (USD Billion)
TABLE NO. 28. U.S. Rheumatology Therapeutics Market Revenue, By Distribution Channel, 2016 – 2028 (USD Billion)
TABLE NO. 29. Canada Rheumatology Therapeutics Market Revenue, By Disease Type, 2016 – 2028 (USD Billion)
TABLE NO. 30. Canada Rheumatology Therapeutics Market Revenue, By Drug Type, 2016 – 2028 (USD Billion)
TABLE NO. 31. Canada Rheumatology Therapeutics Market Revenue, By Distribution Channel, 2016 – 2028 (USD Billion)
TABLE NO. 32. Mexico Rheumatology Therapeutics Market Revenue, By Disease Type, 2016 – 2028 (USD Billion)
TABLE NO. 33. Mexico Rheumatology Therapeutics Market Revenue, By Drug Type, 2016 – 2028 (USD Billion)
TABLE NO. 34. Mexico Rheumatology Therapeutics Market Revenue, By Distribution Channel, 2016 – 2028 (USD Billion)
TABLE NO. 35. Drivers for the Rheumatology Therapeutics Market: Impact Analysis
TABLE NO. 36. Restraints for the Rheumatology Therapeutics Market: Impact Analysis
TABLE NO. 37. Major Buyers of Beverage Packaging
TABLE NO. 38. Distributors/Traders List of Beverage Packaging
TABLE NO. 39. Global Rheumatology Therapeutics Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 40. Global Rheumatology Therapeutics Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)
Methodology
FrequentlyAsked Questions
Rheumatology Therapeutics Market size worth at USD 35.47 Billion in 2023
Rheumatology Therapeutics Market size worth at USD 35.47 Billion in 2023 and projected to USD 44.29 Billion by 2032, with a CAGR of around 2.5% between 2024-2032.
The key factor driving the global Rheumatology Therapeutics Market growth is growing burden of rheumatic diseases around the world.
North America ruled the Rheumatology Therapeutics with highest share for the year 2020 in terms of income followed by Asia Pacific and Europe.
Some of the major companies operating in Rheumatology Therapeutics Market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Takeda Pharmaceutical and Sanofi among others.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed